Komori
Sobal (2186) · RiskDropped

Impact of COVID-19 Infections on Operations and Earnings

First written in FY2022. 3 of 5 entries say "Restated". Latest entry: FY2024.

5entries
3years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2022 – FY20242022: 220222023: 220232024: 12024
Same theme, other companies
Business Disruption Caused by Employee COVID-19 InfectionsA theme 36 companies write about · 35 as a headwind · 1 as a tailwind

The whole theme swung hardest in 2025: 2 of 12 companies on the "Worse" side.

7 other companies' latest entry also says "Dropped".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 36 companies compared. The sentences above are computed from all 36.
Full recordFilings, disclosures and news, newest first
  1. FY2024DroppedAnnual report

    「Japan's economy showed signs of a gradual recovery, supported by a recovery trend in personal consumption and capital investment following the reclassification of COVID-19 as a Class 5 infectious disease.」

    The risk of an impact on operations and business performance in the event of a large-scale outbreak, which had been disclosed independently through the previous filing, is not listed as a separate item in the business risks section of this filing. The economic environment section describes the reclassification as a Class 5 disease and the recovery trend.
  2. FY2023RestatedAnnual report

    「Our group has taken measures to reduce the risk of infection, including recommending telework, holding online meetings and distributing disinfectant. However, if a large-scale outbreak occurs among our group's employees or customers at their places of work, it could affect our group's business performance and financial condition.」

    The measures to reduce infection risk through telework, online meetings and the distribution of disinfectant, and the potential impact of a large-scale outbreak on business performance and financial condition, have been reconfirmed.
  3. FY2023-Q3RestatedAnnual report

    「We will continue to monitor the situation closely regarding the impact of the spread of COVID-19 on the Group's financial condition and operating results.」

    The stance of continuing to monitor the impact of the spread of COVID-19 on financial condition and business performance has been reconfirmed.
  4. FY2023-Q1RestatedAnnual report

    「We will continue to monitor the situation closely regarding the impact of the spread of COVID-19 on the Group's financial condition and operating results.」

    The stance of continuing to monitor the impact of the spread of COVID-19 on financial condition and business performance has been reconfirmed.
  5. FY2022First statedAnnual report

    「Our group has taken measures to reduce the risk of infection, including recommending telework, holding online meetings and distributing disinfectant. However, if a large-scale outbreak occurs among our group's employees or customers at their places of work, it could affect our group's business performance and financial condition.」

    The impact on business performance and financial condition if a large-scale outbreak occurs among employees or customers at their workplaces has been disclosed independently for the first time as a business risk specific to infectious diseases.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Sobal yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Impact of COVID-19 Infections on Operations and Earnings | Sobal Corporation (2186) | Komori